Independent Portfolio Consultants’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $444K | Sell |
13,036
-4,699
| -26% | -$160K | 0.18% | 186 |
|
|
2017
Q1 | $552K | Sell |
17,735
-3,725
| -17% | -$116K | 0.19% | 189 |
|
|
2016
Q4 | $586K | Sell |
21,460
-1,260
| -6% | -$34.4K | 0.19% | 196 |
|
|
2016
Q3 | $738K | Buy |
22,720
+145
| +0.6% | +$4.71K | 0.23% | 150 |
|
|
2016
Q2 | $682K | Sell |
22,575
-1,435
| -6% | -$43.4K | 0.21% | 156 |
|
|
2016
Q1 | $676K | Buy |
24,010
+990
| +4% | +$27.9K | 0.19% | 162 |
|
|
2015
Q4 | $782K | Sell |
23,020
-750
| -3% | -$25.5K | 0.23% | 129 |
|
|
2015
Q3 | $756K | Sell |
23,770
-22,510
| -49% | -$716K | 0.16% | 172 |
|
|
2015
Q2 | $1.47M | Buy |
46,280
+41,660
| +902% | +$1.33M | 0.29% | 114 |
|
|
2015
Q1 | $158K | Sell |
4,620
-410
| -8% | -$14K | 0.03% | 401 |
|
|
2014
Q4 | $177K | Sell |
5,030
-6,550
| -57% | -$230K | 0.04% | 394 |
|
|
2014
Q3 | $414K | Sell |
11,580
-1,980
| -15% | -$70.8K | 0.11% | 284 |
|
|
2014
Q2 | $504K | Sell |
13,560
-1,000
| -7% | -$37.2K | 0.14% | 228 |
|
|
2014
Q1 | $472K | Sell |
14,560
-5,566
| -28% | -$180K | 0.15% | 246 |
|
|
2013
Q4 | $597K | Sell |
20,126
-1,210
| -6% | -$35.9K | 0.21% | 162 |
|
|
2013
Q3 | $554K | Sell |
21,336
-710
| -3% | -$18.4K | 0.22% | 170 |
|
|
2013
Q2 | $521K | Buy |
+22,046
| New | +$521K | 0.23% | 169 |
|